Tirzepatide Online: Physician-Directed Weight Loss
Tirzepatide is a dual GIP/GLP-1 receptor agonist used in medical weight and metabolic care when a clinician determines it fits your history and goals. At Refuvia, licensed clinicians in the HLY Medical Group PA network evaluate whether tirzepatide — or another approach — is medically appropriate for you.
Tirzepatide is one option in a class of medications — not an automatic upgrade from semaglutide. Trial averages for FDA-approved products are not a forecast for you, and compounded products were not the products studied in those trials. Your clinician weighs history, tolerability, goals, and access.
Transparent pricing, physician-directed plans, and fulfillment routing that matches your path: RESTORE · TRANSFORM · THRIVE.
How tirzepatide works (educational)
Like GLP-1 medicines, tirzepatide engages gut-hormone pathways involved in appetite and post-meal physiology. It also acts on GIP (glucose-dependent insulinotropic polypeptide), a second incretin pathway. People may experience reduced appetite and fuller satiety signals; individual responses vary widely.
Brand-name products that contain tirzepatide (for example, Zepbound for chronic weight management and Mounjaro for type 2 diabetes, in labeled indications) are FDA-approved. Compounded tirzepatide is a different category of product. A clinician may prescribe compounded tirzepatide when a patient’s medical needs cannot be met by an FDA-approved drug, and we do not market it as a cheaper substitute for brand.
See also Semaglutide and Compounded vs brand-name GLP-1.
Not an automatic upgrade
| Consideration | Why it matters |
|---|---|
| Tolerability | GI effects and titration pace vary person to person |
| Clinical history | Prior response, contraindications, comorbidities |
| Goals & sustainability | Maintenance planning matters as much as early change |
| Path & access | Brand vs compounded is a clinical + practical decision — not a ranking chart |
Semaglutide remains an appropriate choice for many people.
Two paths your clinician may discuss
1) Compounded all-inclusive path
Starting at $329/mo — when prescribed, marketed as an all-inclusive compounded tirzepatide program (medication, shipping, and protocol visits/check-ins as currently described). Multi-month options may be available; confirm with your care team. Higher doses may cost more.
2) Branded care path (confirmed)
$100/mo flat care fee for ongoing clinical management on a brand-name path. You pay the pharmacy separately for brand medication. Your clinician may prescribe an FDA-approved brand product when appropriate.
Who this tends to suit
Similar general clinical framing as other GLP-1 weight medications: adults with BMI ≥30, or ≥27 with a weight-related condition, after screening for contraindications. Educational only — your clinician decides.
How care works
- Start your free consultation.
- Clinician evaluation via HLY Medical Group PA.
- Labs if needed.
- Shared decision on path (compounded vs brand), dosing approach, and follow-up.
- Ongoing support and adjustments.
Availability: clinicians licensed in your state through the HLY network, subject to service and treatment availability.
Pricing at a glance
| Path | Monthly | What's included |
|---|---|---|
| Compounded all-inclusive | Starting at $329/mo | Medication (when prescribed) + care elements as currently marketed |
| Branded care fee | $100/mo | Clinical management only; you pay pharmacy for brand med |
HSA/FSA: often usable for eligible medical expenses — confirm with your plan administrator. Not guaranteed.
Side effects (high level)
GI symptoms during titration are commonly discussed; serious risks exist and are reviewed in consultation. Individual experience varies. This is not a complete safety list.
Start your free consultation
Explore whether physician-directed care is appropriate for you. A prescription is never guaranteed — your clinician decides.
Frequently asked questions
How much does tirzepatide cost without insurance?
Compounded all-inclusive path has pricing starting at $329/mo. Branded path: $100/mo care fee; brand medication paid separately at the pharmacy.
Is compounded tirzepatide the same as Zepbound or Mounjaro?
No. Compounded medications are not FDA-approved and are not generics of, identical to, or equivalent to those brand products. Clinicians may prescribe compounded therapy when a patient’s medical needs cannot be met by an FDA-approved drug; a brand path is also available when appropriate.
Is tirzepatide better than semaglutide?
Not automatically. Dual-agonist mechanism is clinically interesting; it does not mean everyone should switch or that you will see a specific result. Your clinician helps choose.
Can I use HSA/FSA?
Often for eligible expenses — confirm with your plan administrator.
How do I get started?
Start your free consultation. A licensed clinician evaluates whether treatment — and which path — is appropriate. No prescription is guaranteed.